Site US01012 — Anchorage, Alaska

Site US01012 is a clinical research site located in Anchorage, Alaska, United States 99503.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site US01012 has participated in 1 clinical trials.

Therapeutic areas: Benign Prostatic Hyperplasia, Overactive Bladder.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US01012?

Site US01012 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US01012 conducted?

Site US01012 has 1 clinical trials on record. Their work covers Benign Prostatic Hyperplasia, Overactive Bladder.

Is Site US01012 accredited by Crixeo Health?

Site US01012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US01012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.